StockData
BioNTech SE logo

BioNTech SE (BNTX) stock

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$84.86−0.40 (-0.47%)

Close on Nov 17, 2026Market cap $21.32BP/E –Yield –

BioNTech operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was €456.00M, up 119.5% from the year before. The highest annual figure on record is €13.58B in fiscal 2022.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025€456.00M+119.5%
FY2024Dec 31, 2024€207.70M-96.1%
FY2023Dec 31, 2023€5.37B-60.4%
FY2022Dec 31, 2022€13.58B+1426.1%
FY2021Dec 31, 2021€889.70M–
FY2020Dec 31, 2020-€13.50M–
FY2019Dec 31, 2019-€198.50M–
FY2018Dec 31, 2018-€58.88M–
FY2017Dec 31, 2017-€52.56M–

More BioNTech figures

See a number that looks wrong?